nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Skin disorder—Fingolimod—multiple sclerosis	0.00902	0.0117	CcSEcCtD
Betahistine—Dyspnoea—Fingolimod—multiple sclerosis	0.00828	0.0108	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00818	0.0106	CcSEcCtD
Betahistine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00802	0.0104	CcSEcCtD
Betahistine—Fatigue—Fingolimod—multiple sclerosis	0.00801	0.0104	CcSEcCtD
Betahistine—Dermatitis atopic—Prednisone—multiple sclerosis	0.00781	0.0102	CcSEcCtD
Betahistine—Erythema multiforme—Cladribine—multiple sclerosis	0.00701	0.00911	CcSEcCtD
Betahistine—Immune system disorder—Cladribine—multiple sclerosis	0.00669	0.0087	CcSEcCtD
Betahistine—Asthenia—Fingolimod—multiple sclerosis	0.00666	0.00866	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00665	0.00865	CcSEcCtD
Betahistine—Pruritus—Fingolimod—multiple sclerosis	0.00657	0.00854	CcSEcCtD
Betahistine—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00643	0.00836	CcSEcCtD
Betahistine—Flatulence—Cladribine—multiple sclerosis	0.00636	0.00826	CcSEcCtD
Betahistine—Diarrhoea—Fingolimod—multiple sclerosis	0.00635	0.00826	CcSEcCtD
Betahistine—Dizziness—Fingolimod—multiple sclerosis	0.00614	0.00799	CcSEcCtD
Betahistine—Ill-defined disorder—Cladribine—multiple sclerosis	0.00599	0.00778	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00589	0.0255	CbGpPWpGaD
Betahistine—Headache—Fingolimod—multiple sclerosis	0.00582	0.00757	CcSEcCtD
Betahistine—Malaise—Cladribine—multiple sclerosis	0.00582	0.00756	CcSEcCtD
Betahistine—Erythema multiforme—Azathioprine—multiple sclerosis	0.0057	0.00741	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—IL4R—multiple sclerosis	0.00547	0.0237	CbGpPWpGaD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00545	0.00709	CcSEcCtD
Betahistine—Immune system disorder—Azathioprine—multiple sclerosis	0.00544	0.00708	CcSEcCtD
Betahistine—Discomfort—Cladribine—multiple sclerosis	0.00543	0.00706	CcSEcCtD
Betahistine—Confusional state—Cladribine—multiple sclerosis	0.00531	0.0069	CcSEcCtD
Betahistine—Nervous system disorder—Cladribine—multiple sclerosis	0.00516	0.00671	CcSEcCtD
Betahistine—HRH3—Monoamine Transport—IL1B—multiple sclerosis	0.00516	0.0223	CbGpPWpGaD
Betahistine—Tachycardia—Cladribine—multiple sclerosis	0.00514	0.00668	CcSEcCtD
Betahistine—Skin disorder—Cladribine—multiple sclerosis	0.00511	0.00665	CcSEcCtD
Betahistine—Abdominal distension—Prednisolone—multiple sclerosis	0.00503	0.00653	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—RGS1—multiple sclerosis	0.00501	0.0217	CbGpPWpGaD
Betahistine—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00487	0.00633	CcSEcCtD
Betahistine—Malaise—Azathioprine—multiple sclerosis	0.00473	0.00615	CcSEcCtD
Betahistine—Dyspnoea—Cladribine—multiple sclerosis	0.00469	0.0061	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00468	0.0203	CbGpPWpGaD
Betahistine—Somnolence—Cladribine—multiple sclerosis	0.00468	0.00609	CcSEcCtD
Betahistine—Abdominal distension—Triamcinolone—multiple sclerosis	0.00462	0.00601	CcSEcCtD
Betahistine—Abdominal distension—Methylprednisolone—multiple sclerosis	0.00461	0.006	CcSEcCtD
Betahistine—Asthma—Triamcinolone—multiple sclerosis	0.00459	0.00597	CcSEcCtD
Betahistine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00455	0.00591	CcSEcCtD
Betahistine—Fatigue—Cladribine—multiple sclerosis	0.00454	0.0059	CcSEcCtD
Betahistine—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00451	0.00586	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00443	0.00577	CcSEcCtD
Betahistine—Discomfort—Azathioprine—multiple sclerosis	0.00441	0.00574	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00441	0.0191	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00434	0.0188	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00434	0.0188	CbGpPWpGaD
Betahistine—Feeling abnormal—Cladribine—multiple sclerosis	0.00434	0.00564	CcSEcCtD
Betahistine—Urticaria—Cladribine—multiple sclerosis	0.00418	0.00544	CcSEcCtD
Betahistine—Skin disorder—Azathioprine—multiple sclerosis	0.00416	0.00541	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00403	0.0175	CbGpPWpGaD
Betahistine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00393	0.00512	CcSEcCtD
Betahistine—Hypersensitivity—Cladribine—multiple sclerosis	0.00388	0.00504	CcSEcCtD
Betahistine—Malaise—Mitoxantrone—multiple sclerosis	0.00382	0.00497	CcSEcCtD
Betahistine—Asthenia—Cladribine—multiple sclerosis	0.00378	0.00491	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00378	0.0164	CbGpPWpGaD
Betahistine—HRH3—Monoamine Transport—TNF—multiple sclerosis	0.00374	0.0162	CbGpPWpGaD
Betahistine—Pruritus—Cladribine—multiple sclerosis	0.00372	0.00484	CcSEcCtD
Betahistine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.0037	0.00481	CcSEcCtD
Betahistine—Convulsion—Mitoxantrone—multiple sclerosis	0.00367	0.00478	CcSEcCtD
Betahistine—Abdominal distension—Prednisone—multiple sclerosis	0.00365	0.00475	CcSEcCtD
Betahistine—Hallucination—Methylprednisolone—multiple sclerosis	0.00365	0.00474	CcSEcCtD
Betahistine—Diarrhoea—Cladribine—multiple sclerosis	0.0036	0.00468	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—S1PR1—multiple sclerosis	0.00357	0.0155	CbGpPWpGaD
Betahistine—Discomfort—Mitoxantrone—multiple sclerosis	0.00357	0.00464	CcSEcCtD
Betahistine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00353	0.00459	CcSEcCtD
Betahistine—Confusional state—Mitoxantrone—multiple sclerosis	0.00349	0.00454	CcSEcCtD
Betahistine—Dizziness—Cladribine—multiple sclerosis	0.00348	0.00453	CcSEcCtD
Betahistine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00346	0.0045	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00345	0.015	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00345	0.015	CbGpPWpGaD
Betahistine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00338	0.00439	CcSEcCtD
Betahistine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00336	0.00437	CcSEcCtD
Betahistine—Vomiting—Cladribine—multiple sclerosis	0.00335	0.00435	CcSEcCtD
Betahistine—Rash—Cladribine—multiple sclerosis	0.00332	0.00432	CcSEcCtD
Betahistine—Hallucination—Betamethasone—multiple sclerosis	0.00332	0.00431	CcSEcCtD
Betahistine—Hallucination—Dexamethasone—multiple sclerosis	0.00332	0.00431	CcSEcCtD
Betahistine—Dermatitis—Cladribine—multiple sclerosis	0.00332	0.00431	CcSEcCtD
Betahistine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00331	0.00431	CcSEcCtD
Betahistine—Headache—Cladribine—multiple sclerosis	0.0033	0.00429	CcSEcCtD
Betahistine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00323	0.0042	CcSEcCtD
Betahistine—Angioedema—Prednisolone—multiple sclerosis	0.00318	0.00413	CcSEcCtD
Betahistine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00315	0.0041	CcSEcCtD
Betahistine—Malaise—Prednisolone—multiple sclerosis	0.00314	0.00408	CcSEcCtD
Betahistine—Nausea—Cladribine—multiple sclerosis	0.00313	0.00407	CcSEcCtD
Betahistine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00309	0.00401	CcSEcCtD
Betahistine—Somnolence—Mitoxantrone—multiple sclerosis	0.00308	0.004	CcSEcCtD
Betahistine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00305	0.00396	CcSEcCtD
Betahistine—Asthma—Methotrexate—multiple sclerosis	0.00303	0.00394	CcSEcCtD
Betahistine—Convulsion—Prednisolone—multiple sclerosis	0.00301	0.00392	CcSEcCtD
Betahistine—Fatigue—Mitoxantrone—multiple sclerosis	0.00298	0.00388	CcSEcCtD
Betahistine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00297	0.00386	CcSEcCtD
Betahistine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00296	0.00385	CcSEcCtD
Betahistine—Diarrhoea—Azathioprine—multiple sclerosis	0.00293	0.00381	CcSEcCtD
Betahistine—Discomfort—Prednisolone—multiple sclerosis	0.00293	0.0038	CcSEcCtD
Betahistine—Angioedema—Triamcinolone—multiple sclerosis	0.00292	0.0038	CcSEcCtD
Betahistine—Angioedema—Methylprednisolone—multiple sclerosis	0.00292	0.00379	CcSEcCtD
Betahistine—Hallucination—Prednisone—multiple sclerosis	0.00289	0.00376	CcSEcCtD
Betahistine—Malaise—Triamcinolone—multiple sclerosis	0.00288	0.00375	CcSEcCtD
Betahistine—Malaise—Methylprednisolone—multiple sclerosis	0.00288	0.00374	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00288	0.0125	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—GPR65—multiple sclerosis	0.00288	0.0125	CbGpPWpGaD
Betahistine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00285	0.00371	CcSEcCtD
Betahistine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00284	0.00369	CcSEcCtD
Betahistine—Dizziness—Azathioprine—multiple sclerosis	0.00283	0.00368	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CCR2—multiple sclerosis	0.0028	0.0121	CbGpPWpGaD
Betahistine—Convulsion—Triamcinolone—multiple sclerosis	0.00277	0.0036	CcSEcCtD
Betahistine—Tachycardia—Prednisolone—multiple sclerosis	0.00277	0.0036	CcSEcCtD
Betahistine—Convulsion—Methylprednisolone—multiple sclerosis	0.00277	0.0036	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00276	0.012	CbGpPWpGaD
Betahistine—Urticaria—Mitoxantrone—multiple sclerosis	0.00275	0.00357	CcSEcCtD
Betahistine—Vomiting—Azathioprine—multiple sclerosis	0.00272	0.00354	CcSEcCtD
Betahistine—Rash—Azathioprine—multiple sclerosis	0.0027	0.00351	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.0027	0.00351	CcSEcCtD
Betahistine—Dermatitis—Azathioprine—multiple sclerosis	0.0027	0.00351	CcSEcCtD
Betahistine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00269	0.0035	CcSEcCtD
Betahistine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00269	0.0035	CcSEcCtD
Betahistine—Discomfort—Triamcinolone—multiple sclerosis	0.00269	0.0035	CcSEcCtD
Betahistine—Discomfort—Methylprednisolone—multiple sclerosis	0.00268	0.00349	CcSEcCtD
Betahistine—Headache—Azathioprine—multiple sclerosis	0.00268	0.00349	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00268	0.00348	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00267	0.0116	CbGpPWpGaD
Betahistine—Angioedema—Dexamethasone—multiple sclerosis	0.00265	0.00345	CcSEcCtD
Betahistine—Angioedema—Betamethasone—multiple sclerosis	0.00265	0.00345	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CXCL13—multiple sclerosis	0.00263	0.0114	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCR1—multiple sclerosis	0.00263	0.0114	CbGpPWpGaD
Betahistine—Confusional state—Methylprednisolone—multiple sclerosis	0.00263	0.00342	CcSEcCtD
Betahistine—Immune system disorder—Prednisone—multiple sclerosis	0.00262	0.00341	CcSEcCtD
Betahistine—Malaise—Dexamethasone—multiple sclerosis	0.00262	0.0034	CcSEcCtD
Betahistine—Malaise—Betamethasone—multiple sclerosis	0.00262	0.0034	CcSEcCtD
Betahistine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00261	0.00339	CcSEcCtD
Betahistine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00261	0.00339	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.0026	0.0113	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00258	0.0112	CbGpPWpGaD
Betahistine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00255	0.00332	CcSEcCtD
Betahistine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00255	0.00332	CcSEcCtD
Betahistine—Tachycardia—Triamcinolone—multiple sclerosis	0.00255	0.00331	CcSEcCtD
Betahistine—Nausea—Azathioprine—multiple sclerosis	0.00254	0.00331	CcSEcCtD
Betahistine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00254	0.00331	CcSEcCtD
Betahistine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00253	0.00329	CcSEcCtD
Betahistine—Convulsion—Betamethasone—multiple sclerosis	0.00252	0.00327	CcSEcCtD
Betahistine—Convulsion—Dexamethasone—multiple sclerosis	0.00252	0.00327	CcSEcCtD
Betahistine—Asthenia—Mitoxantrone—multiple sclerosis	0.00248	0.00323	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00246	0.0107	CbGpPWpGaD
Betahistine—Discomfort—Betamethasone—multiple sclerosis	0.00244	0.00317	CcSEcCtD
Betahistine—Discomfort—Dexamethasone—multiple sclerosis	0.00244	0.00317	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.0024	0.0104	CbGpPWpGaD
Betahistine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00237	0.00308	CcSEcCtD
Betahistine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00237	0.00308	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00237	0.0103	CbGpPWpGaD
Betahistine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00237	0.00308	CcSEcCtD
Betahistine—Ill-defined disorder—Prednisone—multiple sclerosis	0.00235	0.00305	CcSEcCtD
Betahistine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00234	0.00304	CcSEcCtD
Betahistine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00233	0.00303	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00233	0.0101	CbGpPWpGaD
Betahistine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00232	0.00302	CcSEcCtD
Betahistine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00232	0.00302	CcSEcCtD
Betahistine—Tachycardia—Betamethasone—multiple sclerosis	0.00231	0.00301	CcSEcCtD
Betahistine—Tachycardia—Dexamethasone—multiple sclerosis	0.00231	0.00301	CcSEcCtD
Betahistine—Angioedema—Prednisone—multiple sclerosis	0.00231	0.003	CcSEcCtD
Betahistine—Dyspepsia—Triamcinolone—multiple sclerosis	0.0023	0.00299	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00229	0.00298	CcSEcCtD
Betahistine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00229	0.00298	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00229	0.00991	CbGpPWpGaD
Betahistine—Malaise—Prednisone—multiple sclerosis	0.00228	0.00296	CcSEcCtD
Betahistine—Urticaria—Prednisolone—multiple sclerosis	0.00226	0.00293	CcSEcCtD
Betahistine—Fatigue—Triamcinolone—multiple sclerosis	0.00225	0.00293	CcSEcCtD
Betahistine—Fatigue—Methylprednisolone—multiple sclerosis	0.00225	0.00292	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00223	0.00964	CbGpPWpGaD
Betahistine—Vomiting—Mitoxantrone—multiple sclerosis	0.0022	0.00286	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—multiple sclerosis	0.00219	0.00285	CcSEcCtD
Betahistine—Convulsion—Prednisone—multiple sclerosis	0.00219	0.00285	CcSEcCtD
Betahistine—Rash—Mitoxantrone—multiple sclerosis	0.00218	0.00284	CcSEcCtD
Betahistine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00218	0.00283	CcSEcCtD
Betahistine—Headache—Mitoxantrone—multiple sclerosis	0.00217	0.00282	CcSEcCtD
Betahistine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00215	0.0028	CcSEcCtD
Betahistine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00215	0.00279	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00214	0.00278	CcSEcCtD
Betahistine—Discomfort—Prednisone—multiple sclerosis	0.00213	0.00276	CcSEcCtD
Betahistine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00209	0.00272	CcSEcCtD
Betahistine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00209	0.00271	CcSEcCtD
Betahistine—Dyspepsia—Betamethasone—multiple sclerosis	0.00209	0.00271	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—IL4—multiple sclerosis	0.00208	0.009	CbGpPWpGaD
Betahistine—Urticaria—Triamcinolone—multiple sclerosis	0.00207	0.0027	CcSEcCtD
Betahistine—Urticaria—Methylprednisolone—multiple sclerosis	0.00207	0.00269	CcSEcCtD
Betahistine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00206	0.00268	CcSEcCtD
Betahistine—Nausea—Mitoxantrone—multiple sclerosis	0.00206	0.00267	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00205	0.0089	CbGpPWpGaD
Betahistine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00205	0.00266	CcSEcCtD
Betahistine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00205	0.00266	CcSEcCtD
Betahistine—Fatigue—Dexamethasone—multiple sclerosis	0.00204	0.00266	CcSEcCtD
Betahistine—Fatigue—Betamethasone—multiple sclerosis	0.00204	0.00266	CcSEcCtD
Betahistine—Nervous system disorder—Prednisone—multiple sclerosis	0.00202	0.00263	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00202	0.00873	CbGpPWpGaD
Betahistine—Tachycardia—Prednisone—multiple sclerosis	0.00201	0.00262	CcSEcCtD
Betahistine—Skin disorder—Prednisone—multiple sclerosis	0.002	0.00261	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CCL5—multiple sclerosis	0.002	0.00867	CbGpPWpGaD
Betahistine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00196	0.00255	CcSEcCtD
Betahistine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00195	0.00254	CcSEcCtD
Betahistine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00195	0.00254	CcSEcCtD
Betahistine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00192	0.0025	CcSEcCtD
Betahistine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00192	0.0025	CcSEcCtD
Betahistine—Malaise—Methotrexate—multiple sclerosis	0.00191	0.00248	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00188	0.00816	CbGpPWpGaD
Betahistine—Urticaria—Dexamethasone—multiple sclerosis	0.00188	0.00245	CcSEcCtD
Betahistine—Urticaria—Betamethasone—multiple sclerosis	0.00188	0.00245	CcSEcCtD
Betahistine—Dizziness—Prednisolone—multiple sclerosis	0.00188	0.00244	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCL3—multiple sclerosis	0.00187	0.00812	CbGpPWpGaD
Betahistine—Asthenia—Triamcinolone—multiple sclerosis	0.00187	0.00244	CcSEcCtD
Betahistine—Asthenia—Methylprednisolone—multiple sclerosis	0.00187	0.00243	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00185	0.00801	CbGpPWpGaD
Betahistine—Pruritus—Triamcinolone—multiple sclerosis	0.00185	0.0024	CcSEcCtD
Betahistine—Pruritus—Methylprednisolone—multiple sclerosis	0.00184	0.0024	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—S1PR1—multiple sclerosis	0.00183	0.00793	CbGpPWpGaD
Betahistine—Convulsion—Methotrexate—multiple sclerosis	0.00183	0.00238	CcSEcCtD
Betahistine—Dyspepsia—Prednisone—multiple sclerosis	0.00182	0.00236	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—PTGER4—multiple sclerosis	0.0018	0.00781	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CCR5—multiple sclerosis	0.0018	0.00781	CbGpPWpGaD
Betahistine—Rash—Prednisolone—multiple sclerosis	0.00179	0.00233	CcSEcCtD
Betahistine—Dermatitis—Prednisolone—multiple sclerosis	0.00179	0.00233	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00179	0.00232	CcSEcCtD
Betahistine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00178	0.00232	CcSEcCtD
Betahistine—Fatigue—Prednisone—multiple sclerosis	0.00178	0.00231	CcSEcCtD
Betahistine—Headache—Prednisolone—multiple sclerosis	0.00178	0.00231	CcSEcCtD
Betahistine—Discomfort—Methotrexate—multiple sclerosis	0.00178	0.00231	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CXCR3—multiple sclerosis	0.00174	0.00755	CbGpPWpGaD
Betahistine—Confusional state—Methotrexate—multiple sclerosis	0.00174	0.00226	CcSEcCtD
Betahistine—Dizziness—Triamcinolone—multiple sclerosis	0.00173	0.00224	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00172	0.00224	CcSEcCtD
Betahistine—Dizziness—Methylprednisolone—multiple sclerosis	0.00172	0.00224	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—RGS1—multiple sclerosis	0.00171	0.00742	CbGpPWpGaD
Betahistine—Feeling abnormal—Prednisone—multiple sclerosis	0.0017	0.00221	CcSEcCtD
Betahistine—Asthenia—Betamethasone—multiple sclerosis	0.0017	0.00221	CcSEcCtD
Betahistine—Asthenia—Dexamethasone—multiple sclerosis	0.0017	0.00221	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCR2—multiple sclerosis	0.00169	0.00734	CbGpPWpGaD
Betahistine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00169	0.0022	CcSEcCtD
Betahistine—Nausea—Prednisolone—multiple sclerosis	0.00169	0.00219	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00168	0.0073	CbGpPWpGaD
Betahistine—Pruritus—Betamethasone—multiple sclerosis	0.00168	0.00218	CcSEcCtD
Betahistine—Pruritus—Dexamethasone—multiple sclerosis	0.00168	0.00218	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—multiple sclerosis	0.00167	0.00218	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00167	0.00725	CbGpPWpGaD
Betahistine—Vomiting—Triamcinolone—multiple sclerosis	0.00166	0.00216	CcSEcCtD
Betahistine—Vomiting—Methylprednisolone—multiple sclerosis	0.00166	0.00215	CcSEcCtD
Betahistine—Rash—Triamcinolone—multiple sclerosis	0.00165	0.00214	CcSEcCtD
Betahistine—Dermatitis—Triamcinolone—multiple sclerosis	0.00164	0.00214	CcSEcCtD
Betahistine—Rash—Methylprednisolone—multiple sclerosis	0.00164	0.00214	CcSEcCtD
Betahistine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00164	0.00213	CcSEcCtD
Betahistine—Urticaria—Prednisone—multiple sclerosis	0.00164	0.00213	CcSEcCtD
Betahistine—Headache—Triamcinolone—multiple sclerosis	0.00164	0.00213	CcSEcCtD
Betahistine—Headache—Methylprednisolone—multiple sclerosis	0.00163	0.00212	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—GPR65—multiple sclerosis	0.00162	0.00704	CbGpPWpGaD
Betahistine—Diarrhoea—Betamethasone—multiple sclerosis	0.00162	0.00211	CcSEcCtD
Betahistine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00162	0.00211	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00159	0.00689	CbGpPWpGaD
Betahistine—Dizziness—Dexamethasone—multiple sclerosis	0.00157	0.00204	CcSEcCtD
Betahistine—Dizziness—Betamethasone—multiple sclerosis	0.00157	0.00204	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CNR1—multiple sclerosis	0.00156	0.00677	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—RGS1—multiple sclerosis	0.00156	0.00674	CbGpPWpGaD
Betahistine—Nausea—Triamcinolone—multiple sclerosis	0.00155	0.00202	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00155	0.0067	CbGpPWpGaD
Betahistine—Nausea—Methylprednisolone—multiple sclerosis	0.00155	0.00201	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—multiple sclerosis	0.00154	0.002	CcSEcCtD
Betahistine—Somnolence—Methotrexate—multiple sclerosis	0.00153	0.00199	CcSEcCtD
Betahistine—Hypersensitivity—Prednisone—multiple sclerosis	0.00152	0.00198	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—multiple sclerosis	0.00152	0.00197	CcSEcCtD
Betahistine—Vomiting—Betamethasone—multiple sclerosis	0.00151	0.00196	CcSEcCtD
Betahistine—Vomiting—Dexamethasone—multiple sclerosis	0.00151	0.00196	CcSEcCtD
Betahistine—Rash—Betamethasone—multiple sclerosis	0.00149	0.00194	CcSEcCtD
Betahistine—Rash—Dexamethasone—multiple sclerosis	0.00149	0.00194	CcSEcCtD
Betahistine—Dermatitis—Betamethasone—multiple sclerosis	0.00149	0.00194	CcSEcCtD
Betahistine—Dermatitis—Dexamethasone—multiple sclerosis	0.00149	0.00194	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00149	0.00194	CcSEcCtD
Betahistine—Fatigue—Methotrexate—multiple sclerosis	0.00149	0.00193	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—CCR1—multiple sclerosis	0.00149	0.00644	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00149	0.00644	CbGpPWpGaD
Betahistine—Headache—Betamethasone—multiple sclerosis	0.00148	0.00193	CcSEcCtD
Betahistine—Headache—Dexamethasone—multiple sclerosis	0.00148	0.00193	CcSEcCtD
Betahistine—Asthenia—Prednisone—multiple sclerosis	0.00148	0.00192	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—GPR65—multiple sclerosis	0.00148	0.00639	CbGpPWpGaD
Betahistine—Pruritus—Prednisone—multiple sclerosis	0.00146	0.0019	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00146	0.00631	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00143	0.00621	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LINGO1—multiple sclerosis	0.00143	0.00618	CbGpPWpGaD
Betahistine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00142	0.00185	CcSEcCtD
Betahistine—Diarrhoea—Prednisone—multiple sclerosis	0.00141	0.00184	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—POMC—multiple sclerosis	0.00141	0.00611	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL10—multiple sclerosis	0.00141	0.0061	CbGpPWpGaD
Betahistine—Nausea—Dexamethasone—multiple sclerosis	0.00141	0.00183	CcSEcCtD
Betahistine—Nausea—Betamethasone—multiple sclerosis	0.00141	0.00183	CcSEcCtD
Betahistine—Urticaria—Methotrexate—multiple sclerosis	0.00137	0.00178	CcSEcCtD
Betahistine—Dizziness—Prednisone—multiple sclerosis	0.00136	0.00177	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—CCR1—multiple sclerosis	0.00135	0.00585	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL13—multiple sclerosis	0.00135	0.00585	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	0.00134	0.00581	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00133	0.00577	CbGpPWpGaD
Betahistine—Vomiting—Prednisone—multiple sclerosis	0.00131	0.00171	CcSEcCtD
Betahistine—Rash—Prednisone—multiple sclerosis	0.0013	0.00169	CcSEcCtD
Betahistine—Dermatitis—Prednisone—multiple sclerosis	0.0013	0.00169	CcSEcCtD
Betahistine—Headache—Prednisone—multiple sclerosis	0.00129	0.00168	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—multiple sclerosis	0.00127	0.00165	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00125	0.0054	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TAGAP—multiple sclerosis	0.00124	0.00536	CbGpPWpGaD
Betahistine—Asthenia—Methotrexate—multiple sclerosis	0.00124	0.00161	CcSEcCtD
Betahistine—Nausea—Prednisone—multiple sclerosis	0.00123	0.00159	CcSEcCtD
Betahistine—Pruritus—Methotrexate—multiple sclerosis	0.00122	0.00159	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCL5—multiple sclerosis	0.00121	0.00525	CbGpPWpGaD
Betahistine—Diarrhoea—Methotrexate—multiple sclerosis	0.00118	0.00153	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00118	0.0051	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00114	0.00494	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00114	0.00494	CbGpPWpGaD
Betahistine—Dizziness—Methotrexate—multiple sclerosis	0.00114	0.00148	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00112	0.00485	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.0011	0.00475	CbGpPWpGaD
Betahistine—Vomiting—Methotrexate—multiple sclerosis	0.0011	0.00143	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCR5—multiple sclerosis	0.00109	0.00473	CbGpPWpGaD
Betahistine—Rash—Methotrexate—multiple sclerosis	0.00109	0.00141	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—multiple sclerosis	0.00109	0.00141	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—S1PR1—multiple sclerosis	0.00108	0.00468	CbGpPWpGaD
Betahistine—Headache—Methotrexate—multiple sclerosis	0.00108	0.0014	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—GPC5—multiple sclerosis	0.00105	0.00456	CbGpPWpGaD
Betahistine—Nausea—Methotrexate—multiple sclerosis	0.00102	0.00133	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00102	0.00442	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000985	0.00426	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL3—multiple sclerosis	0.000962	0.00417	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000958	0.00415	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	0.00095	0.00411	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	0.000939	0.00407	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000926	0.00401	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RGS1—multiple sclerosis	0.00092	0.00398	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000913	0.00396	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000894	0.00387	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000884	0.00383	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000882	0.00382	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GPR65—multiple sclerosis	0.000872	0.00378	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR2—multiple sclerosis	0.00087	0.00377	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000869	0.00376	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	0.000869	0.00376	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000858	0.00372	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.000854	0.0037	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—POMC—multiple sclerosis	0.000854	0.0037	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCL2—multiple sclerosis	0.000835	0.00362	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000813	0.00352	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CNR1—multiple sclerosis	0.000803	0.00348	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL13—multiple sclerosis	0.000797	0.00345	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR1—multiple sclerosis	0.000797	0.00345	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000796	0.00345	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000792	0.00343	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000783	0.00339	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000756	0.00327	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000735	0.00318	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000723	0.00313	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000685	0.00297	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000678	0.00294	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000666	0.00288	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL5—multiple sclerosis	0.000622	0.00269	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	0.000619	0.00268	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000617	0.00267	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000611	0.00265	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000608	0.00263	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000605	0.00262	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000596	0.00258	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000576	0.00249	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL3—multiple sclerosis	0.000568	0.00246	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000566	0.00245	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR5—multiple sclerosis	0.00056	0.00243	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	0.00056	0.00242	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000553	0.0024	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000552	0.00239	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTGER4—multiple sclerosis	0.000547	0.00237	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PGR—multiple sclerosis	0.000539	0.00233	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000537	0.00233	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCR3—multiple sclerosis	0.000528	0.00229	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000526	0.00228	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD28—multiple sclerosis	0.000523	0.00227	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	0.000517	0.00224	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	0.000514	0.00223	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR2—multiple sclerosis	0.000514	0.00223	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000491	0.00213	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000491	0.00213	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	0.000487	0.00211	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—POMC—multiple sclerosis	0.000482	0.00209	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CNR1—multiple sclerosis	0.000474	0.00205	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000474	0.00205	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	0.000471	0.00204	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000465	0.00201	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000446	0.00193	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	0.000446	0.00193	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000444	0.00192	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—POMC—multiple sclerosis	0.000438	0.0019	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL2—multiple sclerosis	0.000429	0.00186	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL10—multiple sclerosis	0.000427	0.00185	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	0.000409	0.00177	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	0.0004	0.00173	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—TYK2—multiple sclerosis	0.000389	0.00169	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD86—multiple sclerosis	0.000373	0.00162	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00037	0.0016	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL5—multiple sclerosis	0.000367	0.00159	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000362	0.00157	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	0.000361	0.00156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	0.000357	0.00155	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2—multiple sclerosis	0.000357	0.00154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	0.000348	0.00151	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SPP1—multiple sclerosis	0.00034	0.00147	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000337	0.00146	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR5—multiple sclerosis	0.000331	0.00143	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2RA—multiple sclerosis	0.000326	0.00141	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000325	0.00141	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—multiple sclerosis	0.000324	0.0014	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	0.000318	0.00138	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000316	0.00137	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000306	0.00132	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	0.000304	0.00132	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOE—multiple sclerosis	0.000301	0.0013	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000295	0.00128	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000292	0.00126	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	0.000288	0.00125	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	0.000287	0.00124	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000283	0.00122	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	0.000282	0.00122	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	0.000276	0.00119	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD80—multiple sclerosis	0.000272	0.00118	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	0.000265	0.00115	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	0.000263	0.00114	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	0.000263	0.00114	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000263	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—POMC—multiple sclerosis	0.000259	0.00112	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL2—multiple sclerosis	0.000253	0.0011	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000248	0.00107	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000239	0.00103	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TYK2—multiple sclerosis	0.00023	0.000996	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000226	0.00098	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000217	0.000941	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	0.000206	0.00089	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000204	0.000883	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000201	0.00087	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—multiple sclerosis	0.000191	0.000829	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—multiple sclerosis	0.00019	0.000824	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	0.000188	0.000813	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	0.000185	0.000802	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000182	0.00079	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—multiple sclerosis	0.000181	0.000784	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	0.000181	0.000782	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PGR—multiple sclerosis	0.000178	0.000771	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	0.000174	0.000756	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD28—multiple sclerosis	0.000173	0.000749	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	0.00017	0.000735	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—multiple sclerosis	0.000161	0.000697	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	0.000159	0.00069	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	0.000157	0.000678	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—multiple sclerosis	0.00015	0.000648	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—multiple sclerosis	0.000149	0.000646	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK1—multiple sclerosis	0.000146	0.000634	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	0.000145	0.000627	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	0.000142	0.000613	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	0.000141	0.000611	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	0.000129	0.000557	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD86—multiple sclerosis	0.000123	0.000534	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	0.000121	0.000526	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	0.000118	0.00051	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—multiple sclerosis	0.000112	0.000487	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	0.000112	0.000487	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	0.000109	0.000474	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	0.000108	0.000467	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	0.000107	0.000463	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOE—multiple sclerosis	9.95e-05	0.000431	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD80—multiple sclerosis	9e-05	0.00039	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—POMC—multiple sclerosis	8.55e-05	0.00037	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	8.36e-05	0.000362	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.18e-05	0.000354	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	7.59e-05	0.000329	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.32e-05	0.000274	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.29e-05	0.000272	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.98e-05	0.000259	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.32e-05	0.00023	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.94e-05	0.000214	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.93e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.83e-05	0.000209	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.71e-05	0.000161	CbGpPWpGaD
